NEW YORK — Biothreat detection technology firm BioFlyte said on Tuesday that it has raised $6.1 million in Series A funding.
The financing round was led by Cottonwood Technology Fund and included existing investor Anzu Partners.
Albuquerque, New Mexico-based BioFlyte was spun off in 2020 from Zeteo Tech, which develops environmental air testing technologies, to commercialize systems for detecting SARS-CoV-2 and other airborne pathogens.
BioFlyte said that it will use the Series A money to support the field validation and initial production of BioTOF z200, a matrix-assisted laser desorption and ionization mass spectrometry-based bio-aerosol detection system for continuous and autonomous operation in critical infrastructure environments. The system consists of a wall mount sensor designed to detect and identify airborne microbes and toxins in real time, the company said. It is expected to launch commercially before the end of the year.
BioFlyte previously raised $1.25 million in seed funding.